Please login or register first to view this content.
Neurologic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Amantadine May Optimize Levodopa Regimen in Parkinson Disease Treatment
Ruzurgi Approved for Pediatric Patients With Lambert-Eaton Myasthenic Syndrome
Fluoroquinolone Use Linked to Increased Peripheral Neuropathy Risk
CBD Gel Gets Fast Tracked for Behavioral Symptoms Associated With Fragile X Syndrome
Rituximab-Related Serious Infections Unlikely in Multiple Sclerosis
Long Half-Life Antiepileptic Drugs Reduce Hospitalization in Uncontrolled Epilepsy
Ocrelizumab Demonstrates Sustained Benefit on Disability Progression in MS
Carbidopa/Levodopa Enteral Suspension Linked to Improved QoL in Advanced Parkinson Disease
Trial Supports Further Development of Huntington Antisense Oligonucleotide Therapy
Thiazide Use May Lower Fracture Risk in Patients With Alzheimer Disease
Glycopyrrolate Injection Now Available in Ready-to-Administer Prefilled Syringes
AAP Updates Guidance for Care in Neurofibromatosis Type 1
Novel Treatment for Neuromyelitis Optica Spectrum Disorder Gets Breakthrough Status From FDA
AEDs Tied to Higher Pneumonia Risk in Alzheimer Patients
Canagliflozin Lowers ESRD Risk in Diabetic Kidney Disease
FDA Warns Against the Use of Unapproved Devices Marketed for Assessing Head Injury
Rituximab Evaluated in Patients With Chronic Fatigue Syndrome
FDA to Review Istradefylline NDA for Parkinson Disease Again
